An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Stereotaxis, a leader in surgical robotics for minimally invasive endovascular intervention, will report its first quarter 2024 financial results on May 13, 2024. The company will host a conference call and webcast to discuss the results and corporate developments.
Stereotaxis, azienda leader nella robotica chirurgica per interventi endovascolari minimamente invasivi, comunicherà i risultati finanziari del primo trimestre del 2024 il 13 maggio 2024. La società ospiterà una conferenza telefonica e un webcast per discutere dei risultati e degli sviluppi aziendali.
Stereotaxis, líder en robótica quirúrgica para intervenciones endovasculares mínimamente invasivas, informará sobre sus resultados financieros del primer trimestre de 2024 el 13 de mayo de 2024. La empresa organizará una llamada de conferencia y una transmisión web para discutir los resultados y los desarrollos corporativos.
최소 침습적 내혈관 개입을 위한 외과 로봇 분야에서 선도하는 스테레오택시스는 2024년 5월 13일에 2024년도 1분기 재무 결과를 보고할 예정입니다. 회사는 결과와 기업 개발에 대해 논의하기 위해 컨퍼런스 콜과 웹캐스트를 주관할 것입니다.
Stereotaxis, un leader dans la robotique chirurgicale pour les interventions endovasculaires minimales invasives, annoncera ses résultats financiers pour le premier trimestre de 2024 le 13 mai 2024. L'entreprise organisera une conférence téléphonique et un webcast pour discuter des résultats et des développements de l'entreprise.
Stereotaxis, ein führender Anbieter in der robotergestützten Chirurgie für minimal-invasive endovaskuläre Eingriffe, wird am 13. Mai 2024 seine Finanzergebnisse für das erste Quartal 2024 bekannt geben. Das Unternehmen wird eine Telefonkonferenz und ein Webcast veranstalten, um die Ergebnisse und Unternehmensentwicklungen zu besprechen.
Positive
None.
Negative
None.
ST. LOUIS, April 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2024 first quarter on Monday, May 13, 2024 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. EST that day to discuss the Company’s results and corporate developments.
What:
Stereotaxis first quarter 2024 financial results conference call
When:
Monday, May 13, 2024, at 4:30 p.m. ET (1:30 p.m. PT)
Dial In Number:
To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 7212885.
Webcast:
To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/.
Call Replay:
A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here.
About Stereotaxis Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.
Investor Contacts: David L. Fischel Chairman and Chief Executive Officer
Kimberly Peery Chief Financial Officer
314-678-6100 Investors@Stereotaxis.com
FAQ
When will Stereotaxis report its first quarter 2024 financial results?
Stereotaxis will report its first quarter 2024 financial results on May 13, 2024.
What time will the conference call discussing Stereotaxis' first quarter 2024 financial results be held?
The conference call discussing Stereotaxis' first quarter 2024 financial results will be held at 4:30 p.m. EST on May 13, 2024.
How can I access the live webcast of the conference call on Stereotaxis' first quarter 2024 financial results?
To access the live webcast of the conference call on Stereotaxis' first quarter 2024 financial results, visit the investor relations section of Stereotaxis' website at http://ir.stereotaxis.com/.
stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. these innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. over 100 issued patents support the stereotaxis platform. the core components of stereotaxis’ systems have received regulatory clearance in the united states, european union, japan, canada, china, and elsewhere. for more information, please visit www.stereotaxis.com.
